Decreased dopamine D2 receptor binding in essential blepharospasm

被引:23
|
作者
Horie, C. [1 ,2 ]
Suzuki, Y. [1 ,2 ]
Kiyosawa, M. [2 ]
Mochizuki, M. [2 ]
Wakakura, M. [3 ]
Oda, K. [1 ]
Ishiwata, K. [1 ]
Ishii, K. [1 ]
机构
[1] Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Itabashi Ku, Tokyo 1730022, Japan
[2] Tokyo Med & Dent Univ, Grad Sch, Dept Ophthalmol & Visual Sci, Tokyo, Japan
[3] Inouye Eye Hosp, Tokyo, Japan
来源
ACTA NEUROLOGICA SCANDINAVICA | 2009年 / 119卷 / 01期
关键词
dopamine D-2 receptor; essential blepharospasm; positron emission tomography; C-11]raclopride; DOPA-RESPONSIVE DYSTONIA; POSITRON-EMISSION-TOMOGRAPHY; BASAL GANGLIA; C-11; RACLOPRIDE; FOCAL DYSTONIA; D2; RECEPTORS; INHIBITION; PET; MUTATION; CARRIERS;
D O I
10.1111/j.1600-0404.2008.01053.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The purpose of this study was to investigate whether dopamine D-2 receptor binding was altered in the striatum of essential blepharospasm patients. Striatal dopamine D-2 receptor binding was measured with positron emission tomography and [C-11]raclopride. We studied eight drug-naive patients with bilateral blepharospasm and eight age-matched normal controls. The uptake indices in the blepharospasm group were significantly reduced by 11.7% in the caudate (P < 0.005), 11.6% in the anterior putamen (P < 0.0001), and 10.3% in the posterior putamen (P < 0.005) relative to the control group. This study indicates decreased dopamine D-2 receptor binding in the entire striatal region of blepharospasm patients. The findings suggest that decreased dopamine D-2 receptor binding might be one of the predisposing factors that leads to the dysfunction of the motor circuit, resulting in the loss of broad inhibition of unwanted movements during an intended movement in blepharospasm patients.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 50 条
  • [41] GABAergic control of neostriatal dopamine D2 receptor binding and behaviors in the rat
    Nikolaus, Susanne
    Beu, Markus
    Silva, Maria Angelica de Souza
    Huston, Joseph P.
    Antke, Christina
    Mueller, Hans-Wilhelm
    Hautzel, Hubertus
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2017, 153 : 76 - 87
  • [42] Dopamine D2 receptor dimer formation -: Evidence from ligand binding
    Armstrong, D
    Strange, PG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (25) : 22621 - 22629
  • [43] Varenicline increases striatal dopamine D2/3 receptor binding in rats
    Crunelle, Cleo L.
    Miller, Michelle L.
    de Bruin, Kora
    van den Brink, Wim
    Booij, Jan
    ADDICTION BIOLOGY, 2009, 14 (04) : 500 - 502
  • [44] Identification of binding determinants for arrestin on D2 dopamine receptor intracellular loops
    Neve, Kim A.
    Lan, Hongxiang
    Liu, Yong
    Teeter, Martha M.
    Gurevich, Vsevolod V.
    FASEB JOURNAL, 2009, 23
  • [45] Altered dopamine D2 receptor function and binding in obese OLETF rat
    Hajnal, Andras
    Margas, Wojciech M.
    Covasa, Mihai
    BRAIN RESEARCH BULLETIN, 2008, 75 (01) : 70 - 76
  • [46] EVIDENCE FOR THE IMPORTANCE OF A CARBOXYL GROUP IN THE BINDING OF LIGANDS TO THE D2 DOPAMINE RECEPTOR
    WILLIAMSON, RA
    STRANGE, PG
    JOURNAL OF NEUROCHEMISTRY, 1990, 55 (04) : 1357 - 1365
  • [47] Ketamine does not decrease striatal dopamine D2 receptor binding in man
    Aalto, S
    Hirvonen, J
    Kajander, J
    Scheinin, H
    Någren, K
    Vilkman, H
    Gustafsson, L
    Syvälahti, E
    Hietala, J
    PSYCHOPHARMACOLOGY, 2002, 164 (04) : 401 - 406
  • [48] Ketamine does not decrease striatal dopamine D2 receptor binding in man
    Sargo Aalto
    Jussi Hirvonen
    Jaana Kajander
    Harry Scheinin
    Kjell Någren
    Harry Vilkman
    Lars Gustafsson
    Erkka Syvälahti
    Jarmo Hietala
    Psychopharmacology, 2002, 164 : 401 - 406
  • [49] Loss of dopamine D2/3 receptor binding in patients with cervical dystonia
    Zoons, E.
    Tijssen, M. A. J.
    Speelman, H. D.
    Booij, J.
    MOVEMENT DISORDERS, 2013, 28 : S43 - S43
  • [50] Mechanisms of ligand binding and efficacy at the human D2(short) dopamine receptor
    Payne, SL
    Johansson, AM
    Strange, PG
    JOURNAL OF NEUROCHEMISTRY, 2002, 82 (05) : 1106 - 1117